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Inflammation is a complex biological response to injuries, metabolic disorders or
infections. In the brain, astrocytes play an important role in the inflammatory processes
during neurodegenerative diseases. Recent studies have shown that the increase of free
saturated fatty acids such as palmitic acid produces a metabolic inflammatory response
in astrocytes generally associated with damaging mechanisms such as oxidative stress,
endoplasmic reticulum stress, and autophagic defects. In this aspect, the synthetic
neurosteroid tibolone has shown to exert protective functions against inflammation
in neuronal experimental models without the tumorigenic effects exerted by sexual
hormones such as estradiol and progesterone. However, there is little information
regarding the specific mechanisms of tibolone in astrocytes during inflammatory
insults. In the present study, we performed a genome-scale metabolic reconstruction
of astrocytes that was used to study astrocytic response during an inflammatory
insult by palmitate through Flux Balance Analysis methods and data mining. In
this aspect, we assessed the metabolic fluxes of human astrocytes under three
different scenarios: healthy (normal conditions), induced inflammation by palmitate,
and tibolone treatment under palmitate inflammation. Our results suggest that tibolone
reduces the L-glutamate-mediated neurotoxicity in astrocytes through the modulation
of several metabolic pathways involved in glutamate uptake. We also identified a set of
reactions associated with the protective effects of tibolone, including the upregulation of
taurine metabolism, gluconeogenesis, cPPAR and the modulation of calcium signaling
pathways. In conclusion, the different scenarios studied in our model allowed us to
identify several metabolic fluxes perturbed under an inflammatory response and the
protective mechanisms exerted by tibolone.
Keywords: tibolone, astrocytes, inflammatory response, flux balance analysis, palmitic acid, genome-scale
reconstruction, systems biology
INTRODUCTION
Astrocytes are the most abundant cells in the human brain. In the last years, it has been shown
that they are of paramount importance for different essential functions in central nervous system
(CNS). For instance, the homeostatic regulation of the central nervous system (Takuma et al., 2004),
tissue repair, modulation of synaptic activity through the release of gliotransmitters and glycogen
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storage (Lange et al., 2012). Additionally, astrocytes protect
neurons against the glutamate-induced excitotoxicity through
the astrocyte-specific sodium-dependent glutamate transporters
such as GLT-1 and GLAST (Bélanger and Magistretti, 2009).
On the other hand, astrocytes are important modulators
of inflammation (Sofroniew, 2014). Their main response to
inflammation happens through the activation of the complex
process of reactive gliosis, which is an important process for CNS
during injuries and diseases (Dowell et al., 2009; Barreto et al.,
2011; Sofroniew, 2014). For these reasons, a great number of
studies have shown that the dysregulation of astrocytic functions
is highly correlated with the development of neurodegenerative
processes, (Takuma et al., 2004; Kumar Jha et al., 2016).
Different works have shown that astrocytes are key mediators
in the brain lipid homeostasis and B-oxidation of fatty acid
(Panov et al., 2014). Interestingly, saturated free fatty acids,
including stearic acid, lauric acid, and palmitic acid, are
closely associated with neurodegenerative processes such as
traumatic brain injury (TmBI), dementia, stroke, epilepsy,
spinal cord injury, Parkinson’s disease (PD) reactive gliosis,
neuroinflammation, and Alzheimer’s disease (AD) (Bruce-Keller
et al., 2001, 2009; White et al., 2009; Gupta et al., 2012;
Little et al., 2012; González-Giraldo et al., 2019). Additionally,
both palmitic acid and stearic acid were shown to increase
the secretion of Aβ amyloid peptide in an AD cellular model
(Amtul et al., 2011). Recent studies in human populations
also point an inverse correlation between clinical obesity and
neuroinflammation (Barnard et al., 2014; Reichelt et al., 2017;
Melo et al., 2019), suggesting that long-term consumption of
high fat diets is associated with pathological mechanisms in the
brain (Melo et al., 2019). Moreover, the increase of saturated
free fatty acids during metabolic inflammation activates IKKβ
kinase and its downstream effector NF-κβ, which in turn
impairs leptin and insulin hormonal signaling and triggers the
production and release of reactive oxygen species (ROS) and
pro-inflammatory cytokines like TNF-α and IL-6 from glial cells
(Purkayastha and Cai, 2013).
In this aspect, tibolone is a synthetic steroid (Kloosterboer,
2001), with estrogenic, progestogenic, and weak androgenic
actions (González-Giraldo et al., 2019). It has been used for the
treatment of climacteric symptoms and osteoporosis in post-
menopausal women (Rymer et al., 1994; Rymer, 1998) and
has also shown beneficial antidepressant effects in menopausal
women (Kulkarni et al., 2015). It has been shown that tibolone
exerts its neuroprotective effects through the activation of
the Akt/GSK3ß signaling pathway which in turns causes the
reduction of Tau phosphorylation in the hippocampus and
cerebellum of ovariectomized rats, the increase in antioxidant
activity in primary neuronal cultures and the increase in the
expression of the antiapoptotic protein Bcl-2 (Genazzani et al.,
2006; Belenichev et al., 2012; Pinto-Almazán et al, 2012; Avila-
Rodriguez et al., 2014). Nevertheless, there is little information
regarding the effects of tibolone in astrocytes or the metabolic
pathways related with its neuroprotective mechanisms (Avila-
Rodriguez et al., 2014; González-Giraldo et al., 2019).
In that sense, genome-scale metabolic reconstructions are a
compilation of all the stoichiometric reactions and pathways
that can describe the entire cellular metabolism of an organism
(Vodovotz et al., 2008; Thiele et al., 2013). In recent years,
they have become an indispensable tool for the understanding
of complex biological phenomena, including neurodegenerative
diseases and inflammation processes (Cakir et al., 2007;
Swainston et al., 2013; Sertbas¸ et al., 2014; Martín-Jiménez et al.,
2017). Moreover, genomic-scale reconstructions are builder from
a system biology approach that allows the integration of several
sources of information, such as biological data bases, high-
throughput omic data, and experimental evidence, in order to
improve the development of novel pharmacological treatments
(Najafi et al., 2014).
Having in account the importance of astrocytes for brain
inflammation, and the promising effects of tibolone for
astrocytic and neuronal protection (Crespo-Castrillo et al.,
2018), we developed a genomic-scale metabolic model of
astrocytes, with the purpose of enlighten the metabolic pathways
modulated by tibolone during an inflammatory response
caused by the increased uptake of palmitate. We focused or
attention, in the identification of metabolic changes related
with the modulation of cytokines, the release of gliotransmitters
and the neuroprotective effects mediated by tibolone in an
inflammatory scenario (Wojtal et al., 2006). Our results
suggest that tibolone exerts its neuroprotective effects through
the reduction of neurotoxicity mediated by L-glutamate in
astrocytes. We also found a tibolone-associated increase in
the biomass growth rate that is consistent with previous
reports concerning the side effects of neurosteroids in other
human cell types.
MATERIALS AND METHODS
Tissue Specific Model Construction
The tissue specific model construction process started with
the identification of all enzyme-coding genes expressed in
healthy human astrocytes indexed in the GEO database
(Swainston et al., 2013) as GSE73721. Gene identifier conversion
from GeneCards (Rebhan et al., 1997) to ENTREZ (Maglott
et al., 2011) was performed through “UniProt.ws” R Package.
Reactions associated with the identified genes were mapped
from the Human Genome-Scale Metabolic Reconstruction
RECON 2.04 (Thiele et al., 2013) as downloaded from the
VMH Lab (Swainston et al., 2016)1 and further enriched
with metabolic information obtained from KEGG (Kanehisa
and Goto, 2000). Additionally, we developed the R package
“g2f” available in CRAN (Hornik, 2012; Botero et al., 2016)
to identify and fill the gaps using all the reactions with
an uncorrelated gene expression included in RECON 2.04,
as well as to select and remove all blocked reactions from
our reconstruction.
All the reactions involved in the conversion of extracellular
glutamate, glycine, cysteine and glucose to extracellular
glutamine, glycine, serine-D, reduced glutathione, lactate, and
ATP were added, as they are essential for the normal astrocytic
1https://vmh.uni.lu
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metabolism (Barreto et al., 2011; Souza et al., 2019). Exchange
reactions were limited to components of the Dulbecco’s Modified
Eagle Medium (DMEM) as an input, and the gliotransmitters,
glutamine, D-serine, ATP and glutamate, reduced glutathione,
lactate, glucose, nitric oxide, prostaglandins and leukotrienes
as output, in accordance with previous experimental studies
from our group (Avila-Rodriguez et al., 2016; Cabezas et al.,
2018; González-Giraldo et al., 2019). Finally, we developed the
R Package “MinVal” to validate the syntax of the model, the
mass-charge and the creation of SBML files (Osorio et al., 2017).
Reaction limits (upper and lower bounds) were constrained
proportionally to the mean gene expression reported for
genes included in Gene-Protein-Reaction (GPR) (Thiele and
Palsson, 2010) associated to each reaction in samples of male
and female human patients from 47 to 63 years old, using
the “exp2flux” R package available in CRAN (Hornik, 2012;
Osorio et al., 2017). All Flux Balance Analysis (FBA) were
performed using the “sybil” (Gelius-Dietrich et al., 2013) R
Package running under R 3.3.1 (Gelius-Dietrich et al., 2013;
R Development Core Team, 2016).
Flux Balance Analysis
Flux balance analysis is a linear optimization method for
simulating the metabolic reactions of a cell or an organism that
allows the identification of the set of reactions involved in the
production of a biological response within the metabolic model
(Orth et al., 2010). The metabolic reactions are represented
internally as a stoichiometric matrix (S), of size m×n, where m
represents the metabolites and n the reactions. The entries in the
matrix are the stoichiometric coefficients of the metabolites that
take part in a reaction. The flux through all of the reactions in
a network is represented by the vector v, which has a length of
n. The concentrations of all metabolites are represented by the
vector x, with length m.
The systems of mass balance equations at steady state are
defined by:
dx
dt
= 0 or S × v = 0. FBA
This expression seeks to maximize or minimize an objective
function, which can be any linear combination of fluxes to obtain
a flux for each reaction, indicating how much each reaction
contributes to the objective function (Orth et al., 2010). The FBA
for the studied scenarios was resolved using GLPK 4.602, setting
the generic human biomass reaction included in RECON 2.04 as
default, and each one of the reactions described in Table 1 as
objective functions. Models for each scenario were analyzed by
comparing their specific fluxes, metabolite’s production rate and
a sensitivity analysis.
Identifying Flux Changes Between
Scenarios
The measurement of flux change for each reaction between
metabolic scenarios is a task generally carried out manually
and oriented directly toward the research objective. However,
2https://sourceforge.net/projects/winglpk/files/winglpk/GLPK-4.60/
TABLE 1 | Set of objective functions used to evaluate the protective effects of
tibolone in the inflammatory scenario.
ID Formula reaction Description
Glu2Gln 1 glu_L[e]→ 1 gln_L[e] Glutamate – Glutamine
cycle
Gly2SerD 1 gly[e]→ 1 ser_D[e] Glycine to D-serine
conversion
Glc2Lac 1 glc_D[e]→ 2 lac_L[e] Lactate production from
glucose
Glc2ATP 1 glc_D[e]→ 36 atp[e] ATP production from
glucose
Cys2GTHRD 1 cys_L[e] + 1
glu_L[c] + 1 gly[c]→ 1
gthrd[e]
Catch of cysteine to
produce reduced
glutathione
at system level this process can become laborious. The flux
Differences function calculates the fold change for each common
reaction between metabolic scenarios.
Fold change is a measure that describes how much a quantity
changes going from an initial to a final value. The implemented
algorithm in the flux Differences function is described in Eq. 1:
foldChange : R × R→ R
(rFluxModel1, rFluxModel2) 7→
rFluxModel2, rFlux Model1 = 0;
rFluxModel1− rFluxModel2∣∣rFluxModel1 ∣∣ , Other cases
(1)
Here, the function takes as argument two valid models for the
“sybil” R package and a customizable threshold value to filter
functions to be reported.
In this aspect, we chose an arbitrary threshold value greater
or equal to 2-fold times for reactions with an absolute
change between the unconstrained and constrained metabolic
scenarios, as reported in previous models (Hausen et al., 2015;
Banos et al., 2017).
Metabolic Scenarios
To test the protective effects of tibolone during metabolic
inflammation in astrocytes we defined three different metabolic
scenarios: (1) A “healthy” scenario, where the rate of palmitate
uptake was set freely by the optimizer. This scenario emulates
the normal conditions of astrocytes metabolism (Supplementary
Data Sheet 1), without any inflammatory response (Seeger et al.,
2016). (2) An “induced inflammation by palmitate” scenario,
where the uptake rate of palmitate was forced to be stable in
the mean of the half maximal inhibitory concentration (IC50)
value for all the objective functions included in Table 1. In
this aspect, IC50 values were calculated through a robustness
analysis performed using uptake of palmitate (‘EXhdca(e)’ in
RECON 2.04) as control and 1000 points in the range from 0
to 1 mMgDW–1h–1 for each objective function. Uptake values
where each objective function reached IC50 was selected and
subsequently averaged. Moreover, the modeled inhibitory effects
Frontiers in Neuroscience | www.frontiersin.org 3 January 2020 | Volume 13 | Article 1410
fnins-13-01410 January 30, 2020 Time: 17:1 # 4
Osorio et al. Pathways Involved in Palmitic Acid Toxicity
TABLE 2 | Set of reactions added to recreate the “Tibolone treatment” scenario
for the astrocytic model.
ID Formula reaction Description
T1 Tibolone[e]↔ Tibolone exchange reaction
T2 Tibolone[e]↔ a3OHtibolone[e] 3ahidroxytibolone interconvertion
T3 Tibolone[e]↔ b3OHtibolone[e] 3bhidroxytibolone interconvertion
T4 Tibolone[e]→ d4tibolone[e] D4tibolone isomer formation
T5 b3OHtibolone[e]→
d4tibolone[e]
D4tibolone isomer formation from
3b-hidroxytibolone
T6 a3OHtibolone[e]→ estradiol[c] Estradiol receptor agonist action
mechanism of 3a-hidroxytibolone
T7 b3OHtibolone[e]→ estradiol[c] Estradiol receptor agonist action
mechanism of 3b-hidroxytibolone
T8 d4tibolone[e]→
prgstrn[c] + tststerone[c]
Progesterone and androgen
receptor activation by tibolone D4
isomer
T9 a3OHtibolone[e]↔
a3SOtibolone[e]
3ahidroxytibolone interconvertion to
sulfated inactive compounds
T10 a3SOtibolone[e]→ Tibolone inactive form in blood
Tibolone reactions affecting the astrocytic metabolism were
based on Kloosterboer (2004).
are in congruence with the reported damaging effects of palmitate
in astrocytes (Gupta et al., 2012; González-Giraldo et al., 2019).
Finally, a “Tibolone treatment under inflammation” scenario
was defined as an “inflammatory scenario” which included
279 additional reactions associated with the metabolic effects
exerted by estradiol and derivates compounds obtained in KEGG
(Kanehisa et al., 2014), and ten specific reactions associated
with tibolone metabolism (Kloosterboer, 2004) not included in
RECON 2.04, which are described in Table 2.
Metabolic Changes
Flux differences for each reaction between optimized scenarios
were measured using the fold change as described in the
following equation:
foldChange = valueModel2− valueModel1∣∣valueModel1∣∣ (2)
Mechanisms of Associated Enzymes
With Pro-inflammatory,
Anti-inflammatory and Tibolone Effects
Enzymes involved in pro-inflammatory and anti-inflammatory
responses during palmitic acid damage and upon tibolone
treatment were identified through a sensitivity analysis as follows:
Pro-inflammatory enzymes are those that catalyze reactions
that allow the increase of the objective function value when
knocked out. Anti-inflammatory enzymes are those associated
with reactions that have a fold-change greater or equal to 2, and
that once being knocked out reduces the objective function value.
Tibolone associated enzymes are those that catalyze reactions that
produce a total inhibition of the metabolic effects of tibolone
when knocked out.
RESULTS AND DISCUSSION
Astrocytic Metabolic Model
We reconstructed an FBA based astrocytic tissue-specific model
composed by 1262 unique genes, 1956 metabolites and 2747
biochemical reactions of which 1607 were intracellular reactions,
60 were exchange reactions, and 1080 were transport reactions
(Figure 1A). Reactions were classified based on their enzymatic
activity according to their EC (Enzyme Commission) numbers
(Figure 1B), and sub-cellular localization (Figure 1C).
Based on the enzymatic classification (Figure 1B), 33.2% of
total reactions are catalyzed by a transferase enzyme, 15.8% by an
oxidoreductase, 14.4% by a hydrolase, 6.2% by a lyase, 2.3% by a
ligase, 1.9% by an isomerase and 25.3% of them are spontaneous
reactions without an associated enzyme or gene associated.
Regarding subcellular localization, cytosolic and mitochondrial
reactions contributed to 60% of the total reactions in the model.
The remaining 40% of reactions are distributed in six subcellular
compartments as follows: 8.7% in Golgi apparatus, 8.5% in
peroxisome, 6.9% in endoplasmic reticulum, 6.3% in lysosome,
4.2% in nucleus, and finally 5.5% are transport reactions from the
extracellular space (Figure 1C).
The reactions included in the model are associated with 113
metabolic pathways reported in the KEGG database (Kanehisa
and Goto, 2000). Almost 50% of reactions are associated
to 10 main metabolic pathways of paramount importance
for astrocytic metabolism and neuronal support such as
oxidative phosphorylation, purine metabolism, glycolysis and
gluconeogenesis, and pentose and glucuronate interconvensions.
The distribution of reactions in metabolic pathways is shown in
Figure 2. These results are similar to those previously reported
astrocytic models (Fitch and Silver, 1997; Ciccarelli et al., 2001;
Çakir et al., 2007; Giaume et al., 2010; Sertbas¸ et al., 2014;
Martín-Jiménez et al., 2017; Sá et al., 2017). For example,
Martín-Jiménez et al. (2017) developed a genome-scale metabolic
reconstruction of human astrocyte, comprising of 5.659 reactions
(237 exchange reactions and 1.948 transport reactions), 3.765
genes, 862 enzymes, 5.007 metabolites. Regarding the subcellular
distribution of reactions, cytosolic and mitochondrial reaction
accounted for 59% of the total reactions, while 23% belonged
to peroxisome, lysosome, endoplasmic reticulum, golgi apparatus
and nucleus. Finally, transport reactions represented 18% of the
total reactions, making them highly similar to our model.
Healthy Scenario (Basal Conditions)
Our metabolic simulation predicts a slow growth rate for
astrocytes (0.37 mMgWD-1h-1) under normal conditions using
DMEM medium as metabolic supply3. This result is in agreement
with the study of Das et al. (2010) which reported that
Human Normal Astrocyte cells (HNA) are able to grow in
DMEM culture medium supplemented with 2% FBS (Das
et al., 2010). Moreover, astrocytes activated 52% of model
reactions (Figure 3) and preferentially use a glucose-based
metabolism. Our model also shows that glucose is catabolized
and constitutively released by astrocytes as lactate without any
3http://himedialabs.com/TD/AT068.pdf
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FIGURE 1 | Distribution of enzymes included in the astrocyte metabolic model. Classification is based in (A) Type of reaction, (B) Catalytic activity and
(C) Associated compartment of the enzyme (subcellular location).
stimuli similar (Le Foll and Levin, 2016), in agreement with Cakir
et al. (2007) and Bhowmick et al. (2015) whom reported a
lactate release rate of 8.9% from the glucose flux in resting
conditions (Çakir et al., 2007; Bhowmick et al., 2015). As
previously stated, astrocytes in physiological conditions release
large amounts of lactate to the extracellular space (Mangia et al.,
2009), which can be used by neurons to supply their energetic
requirements (Kumar Jha et al., 2016). Moreover, our simulations
show that ATP and glutamate are synthesized and released
by astrocytes only under the metabolic alterations present in
the inflammatory and tibolone treatment scenarios which were
analyzed through the evaluated objective functions of our model
(Table 1). Metabolite release rate and biomass growth were used
as references for the comparative changes between the three
metabolic scenarios (Figures 3, 4).
Inflammatory Scenario
In this scenario, we simulated an inflammatory
microenvironment by increasing the cellular concentration
of palmitic acid in astrocytes (Liu et al., 2013; González-Giraldo
et al., 2019). The calculated IC50 for palmitic acid (Table 1)
was 0.208 ± 0.024 mMgDW−1h−1, similar to the study by Liu
et al. (2013) which used a concentration of 0.2 mM of palmitic
acid to induce astrogliosis in primary rat cortical astrocytes
(Liu et al., 2013). Upon palmitic acid, astrocytes increased the
uptake of L-asparagine, L-aspartate, iron, D-glucose, L-glutamate,
histidine and L-serine and the release of L-glutamine and lactate
(Figure 3). This response is usual in reactive astrocytes under
neuroinflammation, which leads to homeostatic disturbances,
including an increased uptake in iron in CNS cells (Kumar
Jha et al., 2016). Iron accumulation is present in several
neurodegenerative diseases such as AD, and PD, promoting
microglial pro-inflammatory activity, altering mitochondrial
function, and inducing ROS production (Williams et al., 2012).
An increase in histidine uptake was previously reported as a
biomarker for metabolic inflammation during obesity (Niu et al.,
2012). In this aspect, histidine acts as a free-radical scavenger
that might reduce IL-6, TNF-α, and CRP levels, and inhibit
the secretion of H2O−2 and TNF-α induced by IL-8 (Lee
et al., 2005; Son et al., 2005). Aspartate, present in the brain
as N-Acetyl-L-aspartate (NAA), is synthesized and stored in
neurons but is hydrolyzed in glial cells (Baslow, 2003). NAA act
as an anti-proliferative, antiangiogenic, and anti-inflammatory
molecule by inducing the decrease of prostaglandin E2 (PGE2)
in astrocytes (Rael et al., 2004). L-Asparagine, in turn, acts
as a regulator of ammonia toxicity through the increase of
Na+ intracellular concentration when is co-transported within
astrocytes (Chaudhry et al., 1999). Moreover, asparagine induces
a Ca2+ response comparable to GABA-induced Ca2+ transients
in a dose-dependent manner (Doengi et al., 2009).
L-serine and L-asparagine uptake increase may be related to a
cell survival process that switches cellular metabolism to be highly
dependent of non-essential amino acids available in extracellular
space such as glutamine, serine, glycine, arginine, and asparagine
(Green et al., 2014). Moreover, under the inflammatory scenario,
our astrocyte model released a limited amount of prostaglandin
D2 (<1e-6 mMgDW-1h-1), a mediator of inflammation. It has
been shown that reactive astrocytes express the DP1 receptor of
prostaglandin D2, and that the inhibition of this receptor resulted
in reactive gliosis suppression in mice (Mohri et al., 2006).
In the inflammatory scenario, astrocytes modified the flux
rate of 586 reactions when compared with the unstimulated
scenario. Main metabolic changes are present in oxidative
phosphorylation, histidine metabolism, and fatty acid
degradation pathways, as well as the inactivation of TCA
and glycolysis pathways (Figure 5). Inflammation affects all
metabolic objective functions evaluated (Table 1) except for the
release of D-serine. In this aspect, it was observed that there was
a decrease of 15.6% in the growth rate of astrocytes compared
with the normal scenario, a decrease of 59.3% in the intake of
cysteine related to reduced glutathione production, a decrease of
72% in glucose degradation to ATP 72%, and to lactate in 74.4%.
Finally, the conversion of extracellular glutamate to glutamine
was reduced by 67.7% (Figure 6).
Based on the sensibility analysis, we identified two pro-
inflammatory candidate reactions that were knocked out
(Table 3). These reactions are associated with the formimidoyl-
transferase cyclodeaminase (FTCD) and mitochondrial water
transport, which has been associated with aquaporin-9 (Potokar
et al., 2016). Following the inhibition of these reactions, it
was observed an increase of the objective function above
the maximum value set for the inflammatory scenario (11.45
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FIGURE 2 | Summary of pathways associated with biochemical reactions included in the genome-scale metabolic model for astrocytes. Pathway association was
assigned based in the metabolic categories used in the KEGG database.
and 5.14%, respectively). In this aspect, it has been shown
that FTCD is overexpressed in high-fat diets (Fernando
et al., 2013) and contributes with one-carbon units from
histidine degradation to the folate pool (Väremo et al., 2015)
and glutamate synthesis. Moreover, this enzyme has been
associated with working memory performance in young adults
(Greenwood et al., 2018). On the other hand, six isoforms
of aquaporins (AQP 1, 3, 4, 5, 8, 9) have been reported
in glial cells, performing important functions like water
transport, regulation of the cerebrospinal fluid (CSF), synaptic
remodeling, formation of brain edemas and inflammatory
processes (Saparov et al., 2007; Te Velde et al., 2008;
Albertini and Bianchi, 2010; Nagahara et al., 2010). Aquaporin
9 (AQP9) is highly expressed in the inner mitochondrial
membrane of astrocytes (Potokar et al., 2016). Different
studies have shown that AQP9 is permeable to many solutes
including glycerol, purines, pyrimidines and urea, suggesting its
importance for diffusion and energetic metabolism in astrocytes
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FIGURE 3 | Exchange rate of metabolites between the different metabolic scenarios using the generic biomass reaction included in RECON 2.04, as the objective
function.
FIGURE 4 | Robustness analysis to calculate palmitate-induced IC50 value for each objective function described in Table 1. The red line represents the calculated
IC50 value.
(Albertini and Bianchi, 2010; Badaut et al., 2012; Potokar et al.,
2016). Moreover, silencing of AQP9 in murine astrocytes
decreased glycerol uptake and increased glucose and oxidative
metabolism, suggesting its importance for astrocyte metabolism
(Badaut et al., 2012). Finally, a study by Nagahara et al. (2010)
showed that in synovial tissues from osteoarthritic patients (OA),
TNFα regulated AQP9 mRNA and protein expression, thus
suggesting that AQP9 could be a biomarker for inflammatory
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FIGURE 5 | Metabolic pathways affected during metabolic inflammation by palmitate. Percentage of activation and inactivation was calculated compared with genes
associated with each pathway in the KEGG database.
FIGURE 6 | The response of the main astrocytes metabolic capabilities to different modeled scenarios. (A) Biomass with DMEm medium, (B) Cystenine to reduced
glutathione conversion, (C) Glucose to ATP conversion, (D) Glucose to lactate conversion, (E) Glutamate to Glutamine conversion, and (F) Glycine to D-serine
conversion.
processes (Nagahara et al., 2010). It is possible that a similar
mechanism could be present in astrocytes under inflammation;
however, additional experimental studies are needed in order to
address this issue.
Finally, 8 anti-inflammatory reactions were found to have
a change equal or greater that 2-fold when knocked-out in
the model (Table 4). 6 of these reactions (r0639, r0653, r0714,
r0716, r0718, and r0720) are involved in fatty acid elongation in
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TABLE 3 | Set of reactions with pro-inflammatory potential, identified through a
sensibility analysis for the inflammatory scenario.
ID Reaction
description
H. Flux I. Flux Fold change
FTCD Formimidoyltransferase
cyclodeaminase
0.39 1.28 2.28
H2Otm H2O transport
mitochondrial
−0.26 2.44 10.44
Fluxes for healthy scenario (H. Flux) and inflammatory scenario (I.
Flux) are compared.
mitochondria through their association with acyl-CoA (Saparov
et al., 2007). This elongation system is responsible for the addition
of two carbon units to the carboxyl end of a fatty acid chain, and
plays an important role in the maintenance of membrane lipid
composition, and in the generation of cell signaling precursors
(such as eicosanoids and sphingosine-1 phosphate), energy
production, and other unknown pathways related with cancer
growth (Murphy et al., 1988; Te Velde et al., 2008).
Our data also showed that AKGMALtm (α-
ketoglutarate/malate transporter) experienced a fold change of
−6.85 when knocked out (Table 4). This transporter is important
for the glutamate/glutamine cycle in astrocytes, which prevents
the excessive accumulation of glutamate in the extracellular
space and the subsequent excitotoxicity (Hertz, 2013). Finally,
the mitochondrial NADH lactate dehydrogenase (LDH) allows
lactate use in ATP production in astrocytes during oxidative
phosphorylation (Lemire et al., 2008). Recently, it was shown
that LDH in murine lymphocyte T cells is important for the
T-cell effector functions by increasing histone acetylation and
the pro-inflammatory IFN-γ transcription, thus suggesting that
LDH could be a therapeutic target in autoinflammatory diseases
(Peng et al., 2016). Further in vivo and in vitro experiments are
needed in order to assess this mechanism in astrocytes.
Tibolone Treatment Scenario
In our “Tibolone treatment” scenario, tibolone affected the flux
rate of 948 reactions in comparison with the inflammatory
scenario. We found important metabolic changes associated with
the activation of several protective pathways in astrocytes
(Schuller-Levis and Park, 2003). These include taurine
metabolism, which has been shown to protect against oxidative
injury in different in vitro and in vivo models including lung cells,
leucocytes, rat macrophages and neuronal cells (Schuller-Levis
and Park, 2003), gluconeogenesis which facilitates the conversion
of fatty acids into ketone bodies under steroid-mediated effects
(Amen-Ra, 2006), calcium, and PPAR signaling path-ways
(Figure 7). Interestingly, PPAR gamma has been shown to
antagonize the actions of pro-inflammatory transcription
factors nuclear factor-κB (NF-κB) and activator protein 1
(AP-1) in human aortic smooth muscle cells and in primary
human hepatocytes (Delerive et al., 2000; Daynes and Jones,
2002). These results suggest that tibolone exerts a significative
modulation on inflammatory reactions through the activation of
several protective pathways, which is agreement with previous
experimental results from our group (Avila-Rodriguez et al.,
2014, 2016; González-Giraldo et al., 2019).
The “tibolone treatment” scenario also increased the demand
for L-aspartate and in turn, decreased the demand for L-
asparagine, L-glutamate and the release of L-glutamine when
compared with the inflammatory scenario (Figure 3). The
reduction on the L-glutamate and L-glutamine uptake/release
rate mediated by tibolone could be associated with a
neuroprotective effect through the reduction in neurotoxicity
mediated by L-glutamate in astrocytes (Petrelli and Bezzi,
2016). In this aspect, it has been shown that the excess in
L-glutamate is a contributing factor in neuronal damage induced
by inflammation in pathologies like TBI stroke, PD and AD
(Ahlemeyer et al., 2002). However, it is important to perform
additional simulations in our model to assess supplementary
metabolic mechanisms that are associated to the induced
inflammation in astrocytes (Shi et al., 2009). Against our
initial hypothesis, tibolone treatment did not show actions
over reactions affected by inflammation and associated with
neuronal support (Table 1). However, tibolone increased cellular
growth by 13.26% compared with basal conditions (Figure 6),
suggesting an increase either on cell viability or in astrocytic
proliferation (Feist and Palsson, 2010). Interestingly, this
proliferative potential was not observed in the inflammatory
scenario, suggesting that the observed proliferation in our model
could be important for cellular homeostasis (Heimann et al.,
2017). In this aspect, previous studies have shown that estrogen
stimulates the differentiation and proliferation of neural stem
cells into neurons, astrocytes, and oligodendrocytes (Okada
et al., 2010). There is no evidence of increased proliferation
TABLE 4 | Set of reactions with anti-inflammatory potential, identified through a sensibility analysis on the inflammatory scenario with palmitate.
ID Reaction description H. Flux I. Flux Fold change
AKGMALtm a-ketoglutarate/malate transporter −0.17 −1.3 −6.85
NADH2_u10 m NADH dehydrogenase mitochondrial 0.12 0.37 2.17
r0639 Lauroyl-CoA: acetyl-CoA C-acyltransferase 0.02 0.09 4.04
r0653 cMyristoyl-CoA: acetyl-CoA C-myristoyl transferase 0.02 0.09 4.04
r0714 (S)-3-Hydroxyhexadecanoyl-CoA: NAD+ oxidoreductase 0.02 0.09 4.04
r0716 (S)-3-Hydroxyhexadecanoyl-CoA hydrolyase 0.02 0.09 4.04
r0718 (S)-3-Hydroxytetradecanoyl-CoA: NAD+ oxidoreductase 0.02 0.09 4.04
r0720 (S)-3-Hydroxytetradecanoyl-CoA hydrolyase 0.02 0.09 4.04
Fluxes for healthy Scenario (H. Flux) and inflammatory scenario (I. Flux) are compared.
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FIGURE 7 | Metabolic pathways affected by tibolone over an inflammatory scenario. Activation and inactivation percentage was measured in comparison with genes
associated to each pathway in the KEGG database.
TABLE 5 | Set of reactions associated with tibolone, involved in the protective
effects of the drug.
ID Reaction description Genes in astrocyte data
r0739 Alcohol Dehydrogenase ADH4, ADH5, ADH7
r2518 ATP-binding Cassette (ABC) ABCD3
RE1804M Cholestanetriol 26-monooxygenase CYP27A1
RE1807M Cholestanetriol 26-monooxygenase CYP27A1
Reactions were identified through a sensibility analysis, carried out in the “Tibolone
treatment” scenario.
by tibolone under palmitate insult, probably due to the
experimental and technical challenges associated with an
accurate measurement of cell proliferation (Frago et al., 2017;
González-Giraldo et al., 2019).
Based on a sensibility analysis performed over 289
reactions associated with tibolone and estradiol-derived
compounds, we identified a set of four reactions that after
being individually knocked out, completely blocked tibolone
effects in our model (Table 5). The identified reactions
are catalyzed by an alcohol dehydrogenase (E.C. 1.1.1.1)
and cholestanetriol 26-monooxygenase associated with
cytochrome P450 and the PPAR signaling pathway (Mast
et al., 2017). Both enzymes were previously reported to be
associated with a reduction in ROS production through
redox reactions mediated by alcohol dehydrogenase (ADH)
and cytochrome P450 (Colditz et al., 1995; Pessayre
et al., 2001). Moreover, a recent study in knockout mice
showed that cholestanetriol 26-monooxygenase deficiency
is associated with early atherosclerosis, osteoporosis, and
progressive neurological deterioration associated with AD
(Mast et al., 2017). Altogether, these results suggest the
importance of tibolone in the regulation of multiple protective
mechanisms in the brain.
CONCLUSION
In this work, we developed a tissue-specific metabolic network
for human astrocytes that was simulated under three different
scenarios. The model allowed us to identify the metabolic changes
between a healthy, an inflammatory and a tibolone treatment
scenario. In our model, the adverse effects associated with the
increase of palmitic acid uptake in astrocytes were described
based on exchange fluxes, metabolite production, and metabolic
pathways perturbed under the inflammatory response. Moreover,
this model was consistent with previous experimental studies
showing that tibolone exerts multiple protective effects against
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inflammation, oxidative stress and metabolic dysregulation (Liu
et al., 2013; Avila-Rodriguez et al., 2014, 2016; González-
Giraldo et al., 2019. In this aspect, a “Tibolone treatment”
scenario was modeled, based on previous works describing
the neuroprotection induced by this synthetic compound on
astrocytes under a variety of anti-inflammatory stimuli.
Our results suggest that tibolone exerts its protective
effects through multiple mechanisms, including the reduction
of neurotoxicity mediated by L-glutamate in astrocytes,
the activation of inflammatory modulators like PPAR
gamma, and the increase in the metabolism of antioxidative
molecules like taurine. We also found a tibolone-associated
increase in biomass growth rate, which is similar to
previously reported studies of the tumorigenic effects
exerted by this compound in breast cancer (Colditz
et al., 1995). On the other hand, the identified enzymes
and reactions associated with tibolone mechanisms are
highly consistent with previous results from our lab
(Avila-Rodriguez et al., 2014, 2016).
Finally, a sensitivity analysis performed through constrained-
based modeling approaches and FBA allowed us to recognize two
possible reactions with their associated enzymes, susceptible to be
knocked out in order to reduce the inflammatory perturbations of
palmitic acid in astrocytes.
In summary, constraint-based models are valuable tools for
the study of the protective effects mediated by pharmacological
molecules in astrocytes, and provide a detailed insight
into high-throughput data analysis. Further experiments are
needed in to confirm the involvement of tibolone in the
regulation of inflammatory mediators in astrocytic animal and
cellular models.
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